about
Contemporary assessment and pharmacotherapy of Tourette syndromeThe Use of Deep Brain Stimulation in Tourette SyndromeAnnual research review: The neurobehavioral development of multiple memory systems--implications for childhood and adolescent psychiatric disordersDeep Brain Stimulation for Tourette's Syndrome: The Case for Targeting the Thalamic Centromedian-Parafascicular ComplexGilles de la Tourette syndrome: the complexities of phenotype and treatmentSlitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalitiesEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentTargeted ablation of cholinergic interneurons in the dorsolateral striatum produces behavioral manifestations of Tourette syndromeOptogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviorsImaging the where and when of tic generation and resting state networks in adult Tourette patients.Tourette syndrome: the self under siege.Altered synaptic plasticity in Tourette's syndrome and its relationship to motor skill learning.Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome.Misplaced Fear? FDA Contraindication to Psychostimulant Use in Children with TicsTic disorders and Tourette's syndrome.PET Neuroimaging: Insights on Dystonia and Tourette Syndrome and Potential ApplicationsFifteen minute consultation: tics and Tourette syndrome.A Review and Update on Tourette Syndrome: Where Is the Field Headed?Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene.Treatment of children and adolescents with tics and Tourette syndrome.Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders.Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and/or obsessive-compulsive disorderDual ameliorative effects of Ningdong granule on dopamine in rat models of Tourette's syndromeMotor excitability during movement preparation in Tourette syndromeTic disorders and obsessive-compulsive disorder: is autoimmunity involved?Annotation: Tourette syndrome: a relentless drumbeat--driven by misguided brain oscillations.Performance Monitoring in Medication-Naïve Children with Tourette Syndrome.Untangling Cortico-Striatal Connectivity and Cross-Frequency Coupling in L-DOPA-Induced Dyskinesia.Motor excitability is reduced prior to voluntary movements in children and adolescents with Tourette syndrome.Memory and executive functions in adults with Gilles de la Tourette syndrome and chronic tic disorder.Deep brain stimulation in Tourette's Syndrome.Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette SyndromePharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.Putting the Pieces Together in Gilles de la Tourette Syndrome: Exploring the Link Between Clinical Observations and the Biological Basis of Dysfunction.Involvement of immunologic and biochemical mechanisms in the pathogenesis of Tourette's syndromeTetrabenazine.Effect of "jian-pi-zhi-dong decoction" on gamma-aminobutyric Acid in a mouse model of tourette syndrome.Internalizing versus externalizing comorbidity: neural circuit hypothesis.Deep brain stimulation therapy for treatment-refractory Tourette's syndrome: A review.Aripiprazole for the treatment of adolescent Tourette's syndrome: a case report.
P2860
Q24607941-97F41198-2E57-41C4-AB2A-6A295AB563A8Q26739914-F3643872-FD58-465F-89C7-24C96ECE3F80Q26864027-33FAE811-E6C9-4E52-AD3E-01DE594B4357Q28076050-094E05DF-98BF-4E0B-B6D9-1F052A12B7CFQ28306632-BEDB7071-28EE-4A0A-823E-C9BA34C7CD34Q28510280-FA1403A9-7C40-49FF-AC11-C2DCF9183382Q28972478-5D8850E7-0B52-417D-B0DA-C7D6D07B2FCEQ30406592-7B537E73-4DD7-4FF0-A00C-EF1506F68C23Q30561087-1A46B883-E35B-4D00-8DF1-18F3F8BF8078Q30578981-A1C4ED17-FE2B-42A2-A4C9-61AC76801320Q33257486-3A4FD06C-D250-42AD-A561-4EB75071E024Q33690107-1F42C475-C971-488C-A4BF-19B68FE25C3AQ33947856-07EF74D0-6978-4A31-BAB2-9F7146698E54Q34075088-EDA12341-E6C9-4D07-A6FA-0B008F322176Q34316548-F0805B23-3139-4FC7-BB0C-2D5127D2B6D8Q34442368-A57A1210-2418-4574-BA08-491F76DC30B2Q34495309-DCFB3944-0BA5-4D45-99E2-910245822291Q34516696-F37B500A-DEEA-46D1-B044-02B13F7B36C4Q34547395-B8FBC7F3-9358-40D2-93B3-B7ED08830D45Q34565872-60B10A45-AB2D-493B-937B-8B9E195A5DD4Q34613057-790EB5A2-14E2-4AB2-B621-35DD9E85B54CQ34775067-B7683A93-F42D-4D37-8745-32D7F9D4F65DQ34975245-B43D987B-4344-48F0-ADBE-2938B70CAFA1Q35219542-1DBCC5B0-ABEC-4144-A7E4-DB6E7E92A891Q36364210-3340B2DD-4BAB-475B-8287-8A1CAA006D92Q36483193-BF7BD095-38F6-417E-ACDC-0DD4A1FFB99DQ36633009-E37BA4EE-EFFB-4106-9DA0-4DFC80E0E3E6Q36740885-DC804B7E-1E25-496A-A81F-A790B5B8D09AQ36745011-56FD3821-BECD-49B7-89FE-84814B0AFF81Q37109972-CE5CB866-F9BF-4E78-A2EE-B1F4D9195FE5Q37131281-0D8EEC31-F51D-4B00-A7EA-B28F4ABD7F99Q37246827-4AE028DB-9800-46F4-B2E7-D5BA3BCD4266Q37419211-C306B895-C61F-4B81-84B9-E981A7B39030Q37568876-927EFFCE-A7C7-4CFB-8D90-511C28C618D7Q37607298-8DD008AF-AB96-406C-89C4-C6C3E897B043Q37636156-60BF7B78-C9E0-4348-BD9F-6CA6E899DA4FQ37724959-0DBDFE2E-8736-43E1-BC75-895C25C0C3D2Q37732221-5DA05489-311C-423E-A525-49B48678D30DQ37790312-91F96A60-EF65-458E-B0CD-C780805DF713Q37867282-90148014-BD48-46EA-B0B6-DF267787516D
P2860
description
article publié dans la revue scientifique The Lancet
@fr
im November 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Lancet
@en
наукова стаття, опублікована в листопаді 2002
@uk
ശാസ്ത്രപ്രബന്ധം
@ml
name
Tourette's syndrome
@en
type
label
Tourette's syndrome
@en
prefLabel
Tourette's syndrome
@en
P1433
P1476
Tourette's syndrome
@en
P2093
James F Leckman
P304
P356
10.1016/S0140-6736(02)11526-1
P407
P577
2002-11-01T00:00:00Z